Functions of CAFs in microenvironment of non-small cell lung cancer: based on updated hallmarks of cancer

被引:1
|
作者
Feng, Xiaoyan [1 ]
Zhu, Binghan [3 ]
Peng, Yali [1 ]
Zhang, Kaiyuan [3 ]
Wang, Yangchun [1 ]
Huang, Guichun [2 ]
Li, Yan [1 ,3 ]
机构
[1] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch,Dept Resp Med, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Med Sch, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll, Dept Resp Med, Nanjing, Jiangsu, Peoples R China
关键词
non-small cell lung cancer; tumor microenvironment; cancer-associated fibroblasts; tumor biology; resistance to antineoplastic therapy; cancer hallmarks; DRUG-RESISTANCE; FIBROBLASTS; INVASION; PROMOTE; AXIS;
D O I
10.1515/oncologie-2024-0232
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-small cell lung cancer (NSCLC) is the most common subtype of lung cancer, which ranks as the first malignant tumor in mortality. The occurrence and development of NSCLC are closely related to the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) in the tumor microenvironment are considered to be critical regulators of the occurrence and development of NSCLC, which have essential effects on multiple biological characteristics of NSCLC. The hallmarks of cancer biology have been updated recently, however, there are no reviews revisiting the function of CAFs in tumor microenvironment. This article reviews the origin, markers, and classification of CAFs, their impacts on the characteristics of NSCLC, and potential therapeutic targets of CAFs to help develop individualized treatment plans for NSCLC.
引用
收藏
页码:701 / 709
页数:9
相关论文
共 50 条
  • [41] Cetuximab in non-small cell lung cancer
    Ademuyiwa, Foluso O.
    Hanna, Nasser
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (01) : 107 - 113
  • [42] Mobocertinib in non-small cell lung cancer
    Liu, Shengwu
    Lowder, Kristen E.
    DRUGS OF TODAY, 2022, 58 (11) : 523 - 530
  • [43] Testin is a tumor suppressor in non-small cell lung cancer
    Wang, Ming
    Wang, Qian
    Peng, Wen-Jia
    Hu, Jun-Feng
    Wang, Zu-Yi
    Liu, Hao
    Huang, Li-Nian
    ONCOLOGY REPORTS, 2017, 37 (02) : 1027 - 1035
  • [44] The increasing role of amphiregulin in non-small cell lung cancer
    Busser, B.
    Coll, J. -L.
    Hurbin, A.
    PATHOLOGIE BIOLOGIE, 2009, 57 (7-8): : 511 - 512
  • [45] Role of AXL expression in non-small cell lung cancer
    Qu, Xiaohan
    Liu, Jinlu
    Zhong, Xinwen
    Li, Xi
    Zhang, Qigang
    ONCOLOGY LETTERS, 2016, 12 (06) : 5085 - 5091
  • [46] Role of microRNAs in the metastasis of non-small cell lung cancer
    Li, Shenglei
    Gao, Ming
    Li, Zongming
    Song, Lijie
    Gao, Xianzheng
    Han, Jing
    Wang, Feng
    Chen, Yongfang
    Li, WenCai
    Yang, Jianping
    Han, Xinwei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 998 - 1005
  • [47] Mechanisms of resistance to chemotherapy in non-small cell lung cancer
    Min, Hye-Young
    Lee, Ho-Young
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (02) : 146 - 164
  • [48] Constructing and identifying an eighteen-gene tumor microenvironment prognostic model for non-small cell lung cancer
    Li, Zaishan
    Meng, Zhenzhen
    Xiao, Lin
    Du, Jiahui
    Jiang, Dazhi
    Liu, Baoling
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [49] An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer
    Finkle, Joshua H.
    Penney, Bill C.
    Pu, Yonglin
    LUNG CANCER, 2018, 123 : 136 - 141
  • [50] The antitumor effect of diisopropylamine dichloroacetate on non-small cell lung cancer and its influence on the tumor immune microenvironment
    Wei, Min
    Shen, Xiaoyan
    Liu, Ye
    Chen, Xiaotong
    Su, Shu
    Lv, Xin
    Qian, Xiaoping
    Yu, Lixia
    Wang, Lifeng
    FRONTIERS IN ONCOLOGY, 2024, 14